Vaginal Swab Detects Molecular Signals for Endometrial Cancer
A peer-reviewed study suggests molecular signatures can be identified without invasive uterine sampling using whole-transcriptome sequencing and machine learning.
Tag: molecular diagnostics
All
Latest
All
Latest
Roche Launches Respiratory Pathogen Panel With Flexible Syndromic Testing for CE Markets
Roche has launched the cobas eplex RP3 panel for CE-markets, enabling simultaneous detection of up to 25 respiratory pathogens with customizable configurations, according to the company.
All
Latest
Insight Molecular Diagnostics Nears FDA Submission for Kidney Transplant Rejection Test Kit
Insight Molecular Diagnostics has completed clinical validation and received ISO 13485 certification for its GraftAssureDx kidney transplant rejection test kit, moving toward FDA submission, according to the company.
Study Finds Test Helps Distinguish Infection From Inflammation in Bone Marrow Transplant Patients
Research in bone marrow transplant patients with blood cancers and febrile neutropenia suggests the host-response test may help identify infection in high-risk populations.
Read More
FDA Grants Breakthrough Status to Breath Test for Postoperative Pneumonia Risk
The FDA has granted Breakthrough Device Designation to Breath Diagnostics Inc.’s OneBreath, a breath-based test that assesses postoperative pneumonia risk in cardiac surgery patients using a single preoperative sample.
Read More
Illumina Announces NovaSeq X Performance Upgrades Including Q70 Quality Scores
Illumina has announced an 18-month roadmap for NovaSeq X, featuring a 40% output increase to 35 billion reads, faster turnaround times, new flow cell options, and the introduction of Q70 quality scores.
Read More
NeoGenomics Launches PanTracer Pro for Solid Tumor Testing
The integrated testing approach combines genomic profiling with immunohistochemistry to support faster treatment decisions for advanced-stage cancer patients.
Read More
New ctDNA Assay Aims to Detect Molecular Residual Disease Earlier in Solid Tumors
Tumor-informed blood test uses whole-exome sequencing and bioinformatics to identify trace tumor DNA before recurrence appears on imaging.
Read More
Syndex Bio Unveils DNA Methylation Technology After $15.5M Funding Round
The mcPCR platform enables copying of DNA methylation patterns during amplification, addressing a key limitation in current PCR methods for disease detection.
Read More
CDC Selects Cepheid as National Collaborator for Rapid Diagnostic Development
The CDC has named Cepheid one of four national collaborators to accelerate rapid diagnostic assay development for public health emergencies under a new federal initiative and IDIQ contract.
Read More
Illumina Secures CMS Reimbursement for TruSight Oncology Test
Illumina’s FDA-approved TruSight Oncology test will be reimbursed by CMS at $2,989.55 per test starting Jan. 1, 2026, enabling broader laboratory access to genomic profiling for Medicare beneficiaries.
Read More
Blood Test Could Detect Parkinson’s Disease Before Symptoms Appear
Researchers have identified blood biomarkers that may enable detection of Parkinson’s disease up to 20 years before symptoms.
Read More
Circular Genomics Secures Exclusive Rights to Blood Test Technology for Alzheimer’s Disease
Circular Genomics has secured exclusive rights from Washington University and Max Delbrück Center to develop a blood-based Alzheimer’s test using circular RNA biomarkers.
Read More
BillionToOne Launches Two Liquid Biopsy Add-On Tests for Cancer Therapy Selection
BillionToOne has launched Northstar PGx and Northstar Select CH, two liquid biopsy add-on tests for advanced solid tumor therapy selection, enabling pharmacogenomic insights and clonal hematopoiesis detection from a single blood draw.
Read More
Blood Test Detects Early-Stage Cancer Using DNA Methylation Patterns
Johns Hopkins researchers have developed a liquid biopsy that detects early-stage lung and breast cancers by measuring DNA methylation variation, showing high accuracy in a study published in Clinical Cancer Research.
Read More
nRichDX and Hamilton Expand Automated Liquid Biopsy Sample Prep Capabilities
nRichDX and Hamilton have integrated the Revolution Plus Sample Prep System with the Microlab STAR platform, enabling automated extraction of cfDNA, cfRNA, cfTNA, and CTCs from sample volumes of 1 to 100 mL.
Read More
FDA Approves Companion Diagnostic for Colorectal Cancer Treatment
The FDA has approved a companion diagnostic for identifying BRAF V600E-mutant metastatic colorectal cancer patients eligible for encorafenib combination therapy.
Read More
Researchers Identify Four New Markers for Detecting Aggressive Breast Cancer Cells in Blood
Researchers at Baylor College of Medicine have identified four new protein markers that improve detection of triple-negative breast cancer cells in blood, potentially enhancing the accuracy of liquid biopsy tests, according to a recent study.
Read More